📰 Cellular Pathology News
Cellular Pathology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cellular Pathology. Real-time updates on events, politics, business and more.
April 19, 2024
The University strikes an agreement to produce a novel meningitis-B vaccine with the Serum Institute of India, the world’s largest vaccine manufacturer.
September 1, 2023
This article will be released in full online September 25, 2023. In the history of Marxism since Karl Marx's death, Frederick Engels has cut a controversial…
August 23, 2023
/PRNewswire/ -- Synthetica Bio, a privately held healthcare technology company developing an enterprise-grade, generative artificial intelligence (GenAI)...
June 30, 2023
This funding will be used to research multiple health conditions, including alcohol-related liver disease, Alzheimer’s disease, breast cancer, heart failure, inflammatory bowel disease and Zhu-Tokita-Takenouchi-Kim syndr...
November 27, 2022
The prizewinning author’s timely, precise study traces our attempts to understand the units that have such an impact on our health
November 14, 2022
Surgeon reveals why animal welfare is so important, and why partnering with surgeons is the best way to advance medicine
October 13, 2022
Cancer pain is a common symptom of advanced cancer. Cancer pain not only seriously affects the quality of ...
August 9, 2022
These changes, seen in a mouse model, are a likely proteome signature for reductive stress cardiomyopathy. About one in six heart failure patients shows reductive stress, according to a 2018 clinical study
August 3, 2022
Two years ago, University of Alabama at Birmingham researchers and colleagues reported that reductive stress -; an imbalance in the normal oxidation/reduction, or redox, homeostasis -; caused pathological changes associated with heart failure in a mouse model.
June 8, 2022
StatLab expands global reach and core manufacturing capabilities with CellPath Ltd. acquisition StatLab Medical Products (StatLab), an Audax Private Equity and Linden Capital Partners portfolio